CRISPR/Cas9 technology has revolutionized genetic engineering of primary cells. Although its use is gaining momentum in studies on CD8+ T cell biology, it remains elusive to what extent CRISPR/Cas9 af
Control CRISPR gRNA against no target in HepG2 cells followed by RNA-seq. (NT-BGHcLV07-B) For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov
Herein, we present the uncropped raw gel images associated with our manuscript titled " Enhancement of CRISPR-Cas12a System through Universal Circular RNA Design ," published in Cell Reports M
